Literature DB >> 17590546

Vitrification from solution in restricted space: formation and stabilization of amorphous nifedipine in a nanoporous silica xerogel carrier.

Aljaz Godec1, Uros Maver, Marjan Bele, Odon Planinsek, Stane Srcic, Miran Gaberscek, Janko Jamnik.   

Abstract

PURPOSE: The goal was to find thermodynamic criteria that must be satisfied in order to prevent formation of crystalline state of drugs within a confined space (e.g., nanopores of inorganic solid). Similarly, criteria that lead to stabilization of amorphous drug within such pores were investigated.
METHODS: In the theoretical part, the classical thermodynamics of nucleation is applied to the conditions of a restricted space. The theoretical findings are verified using porous silica as a carrier and nifedipine as a model drug. The amorphicity of the latter is checked using XRD and thermal analysis (DTA, DSC) in combination with BET measurements.
RESULTS: It is shown that there exists a critical pore radius of a host below which the entrapped substance will solidify in an amorphous form. There also exists a critical pore radius below which the entrapped amorphous solid will not be able to crystallize. Specifically, incorporation of NIF into a silica xerogel with an average pore diameter of about 2.5 nm produces and stabilizes its amorphous form.
CONCLUSION: Entrapment of drugs into solid nanoporous carriers could be regarded as a potentially useful and simple method for production and/or stabilization of non-crystalline forms of a wide range of drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590546     DOI: 10.1016/j.ijpharm.2007.05.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Moringa coagulant as a stabilizer for amorphous solids: Part I.

Authors:  Santosh Bhende; Namdeo Jadhav
Journal:  AAPS PharmSciTech       Date:  2012-02-23       Impact factor: 3.246

2.  Solid formulation of a supersaturable self-microemulsifying drug delivery system for valsartan with improved dissolution and bioavailability.

Authors:  Dong Woo Yeom; Bo Ram Chae; Jin Han Kim; Jun Soo Chae; Dong Jun Shin; Chang Hyun Kim; Sung Rae Kim; Ji Ho Choi; Seh Hyon Song; Dongho Oh; Se Il Sohn; Young Wook Choi
Journal:  Oncotarget       Date:  2017-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.